SEC Form 5 · accession 0001209191-15-013823
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Crowley
Officer — Chairman & CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 13, 2015 · 6:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 18, 2014 | G | 25,584 | $0.00 | D | 83,499 | D | |
| Common Stock | holding | — | — | — | 64,895 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Crowley transferred 25,584 shares to the Crowley Family Donor Advised Fund at the University of Notre Dame.